Keyphrases
Lymphoma
100%
Rheumatoid Arthritis
100%
Methotrexate
100%
Anti-tumor Necrosis Factor Therapy
100%
Confidence Interval
53%
Standardized Incidence Ratio
46%
Treatment Group
15%
Etanercept
15%
Infliximab
15%
Rheumatic Diseases
7%
Clinical Trials
7%
Clinical Practice
7%
High Risk
7%
Rheumatoid Arthritis Patients
7%
National Database
7%
Small Sample Size
7%
Male Sex
7%
Epidemiology
7%
Increasing Age
7%
Sufficient Evidence
7%
Causal Relationship
7%
Rheumatoid Arthritis Treatment
7%
Spontaneous Reporting
7%
Expected number
7%
Channeling Bias
7%
Cancer Data
7%
Medicine and Dentistry
Tumor Necrosis Factor
100%
Rheumatoid Arthritis
100%
Methotrexate
100%
Standardized Incidence Ratio
66%
Group Therapy
22%
Infliximab
22%
Etanercept
22%
Population Research
11%
Malignant Neoplasm
11%
Clinical Trial
11%
Biological Product
11%
Cohort Effect
11%
Rheumatic Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Methotrexate
100%
Tumor Necrosis Factor
100%
Standardized Incidence Ratio
66%
Infliximab
22%
Etanercept
22%
Malignant Neoplasm
11%
Population Study
11%
Clinical Trial
11%
Biological Product
11%
Rheumatic Disease
11%